Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models / Festuccia, C., Gravina, G.L., Marampon, F., Biordi, L.A., Ricevuto, E., Ficorella, C., Tombolini, V.. - In: EUROPEAN JOURNAL OF CANCER. SUPPLEMENT. - ISSN 1359-6349. - STAMPA. - 8:7(2010), pp. 62-63. (22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutic Berlin, GERMANY NOV 16-19, 2010) [10.1016/s1359-6349(10)71889-9].
Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models
F. Marampon;TOMBOLINI, Vincenzo
2010
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


